首页|补骨脂素对人牙周膜干细胞增殖、成骨分化的促进作用及其机制

补骨脂素对人牙周膜干细胞增殖、成骨分化的促进作用及其机制

扫码查看
目的 观察补骨脂素对人牙周膜干细胞(hPDLSCs)增殖、成骨分化的促进作用,并探讨其机制。方法 将第三代hPDLSCs分为6组,5、10、25、50、100 μmol/L补骨脂素组加入5、10、25、50、100 μmol/L补骨脂素,对照组正常培养,采用CCK-8法检测细胞增殖能力,比色法检测碱性磷酸酶(ALP)活性,茜素红染色检测成骨诱导矿化结节。另取第三代hPDLSCs并分为两组,25 μmol/L补骨脂素组加入25 μmol/L补骨脂素,对照组正常培养,采用RT-PCR法检测转录因子2(Runx2)、骨桥蛋白(OPN)mRNA。结果 与对照组比较,5、10、25、50、100 μmol/L补骨脂素组细胞增殖能力和ALP活性增加,25 μmol/L补骨脂素组细胞成骨矿化结节增加(P均<0。05);与5 μmol/L补骨脂素组比较,25、50、100 μmol/L补骨脂素组细胞增殖能力及10、25 μmol/L补骨脂素组细胞ALP活性和25 μmol/L补骨脂素组细胞成骨矿化结节增加(P均<0。05);与10 μmol/L补骨脂素组比较,25、50、100 μmol/L补骨脂素组细胞增殖能力增加(P均<0。05);与25 μmol/L补骨脂素组比较,50、100 μmol/L补骨脂素组细胞ALP活性降低(P均<0。05)。与对照组比较,25 μmol/L补骨脂素组Runx2、OPN mRNA相对表达量增加(P均<0。05)。结论 5~100 μmol/L补骨脂素均能促进hPDLSCs的增殖和成骨分化,在5~25 μmol/L呈剂量依赖性增强,在50~100 μmol/L变化不明显;补骨脂素促进hPDLSCs的增殖和成骨分化的机制可能与调节Runx2信号通路有关。
Promotional effects and mechanism of psoralen on proliferation and osteogenic differentiation of human periodontal ligament stem cells
Objective To observe the promotional effects of psoralen on proliferation and osteogenic differentiation of human periodontal ligament stem cells(hPDLSCs),and to explore their mechanism.Methods The third-generation hPDLSCs were divided into six groups:the control group and 5,10,25,50 and 100 μmol/L psoralen groups,respective-ly.HPDLSCs in the 5,10,25,50 and 100 μmol/L psoralen groups were treated with 5,10,25,50 and 100 μmol/L psoralen,and hPDLSCs in the control group were cultured normally.Cell proliferation capacity was measured by CCK-8 assay,alkaline phosphatase(ALP)activity by colorimetric method,and mineralization nodules by alizarin red staining.Another third-generation hPDLSCs were divided into two groups:the control group and 25 μmol/L psoralen group.Cells in the 25 μmol/L psoralen group were treated with 25 μmol/L psoralen,while cells in the control group were cultured nor-mally.Transcription factor 2(Runx 2)and osteopontin(OPN)mRNA were detected by RT-PCR.Results Compared with the control group,cell proliferation capacity and ALP activity increased in the 5,10,25,50 and 100 μmol/L pso-ralen groups,and mineralization nodules increased in the 25 μmol/L psoralen group(all P<0.05).Compared with the 5 μmol/L psoralen group,cell proliferative capacity increased in the 25,50 and 100 μmol/L psoralen groups,ALP activity increased in the 10 and 25 μmol/L psoralen groups,and mineralization nodules increased in the 25 μmol/L psoralen group(all P<0.05).Compared with the 10 μmol/L psoralen group,cell proliferation capacity increased in the 25,50 and 100 μmol/L psoralen groups(all P<0.05).Compared with the 25 μmol/L group,ALP activity decreased in the 50 and 100 μmol/L psoralen groups(all P<0.05).Compared with the control group,relative expression levels of Runx 2 and OPN mRNA increased in the 25 μmol/L psoralen group(all P<0.05).Conclusions Psoralen of 5-100 μmol/L pro-motes the proliferation and osteogenic differentiation of hPDLSCs.It shows a dose-dependent enhancement at 5 to 25 μmol/L,and there is no obvious change at 50 to 100 μmol/L.The mechanism of psoralen promoting the proliferation and osteogenic differentiation of hPDLSCs may be related to the regulation of Runx 2 signaling pathway.

psoralenperiodontal ligament stem cellscell proliferationosteogenic differentiationtranscription factor 2osteopontin

韩敏、张韶君、席迅

展开 >

山东第一医科大学第一附属医院(山东省千佛山医院)口腔科,济南 250014

补骨脂素 牙周膜干细胞 细胞增殖 成骨分化 转录因子2 骨桥蛋白

山东省自然科学基金青年基金

ZR2023QH421

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(12)
  • 29